N-acetylcysteine in clinical sepsis: a difficult marriage
AUTOR(ES)
Spapen, Herbert
FONTE
BioMed Central
RESUMO
The high morbidity and mortality of severe sepsis and septic shock fosters a continuous search for novel therapies that go beyond pure correction of oxygenation and hemodynamics. Within this scope, N-acetylcysteine shows great promise. Beside proven anti-oxidant, anti-inflammatory and cytoprotective effects, N-acetylcysteine does also ensure endothelial protection and enhances microvascular blood flow. Studies that put these highly favourable properties to the clinical test remain scarce but are definitely needed to determine whether N-acetylcysteine has a place in our therapeutic armamentarium against sepsis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=522849Documentos Relacionados
- N-acetylcysteine inhibits muscle fatigue in humans.
- Evaluation of topical n-acetylcysteine in diversion colitis
- N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
- Oral N‐acetylcysteine for acute paracetamol poisoning
- N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial